Transition to Chronic Fibrosis in an Animal Model of Retinal Detachment With Features of Proliferative Vitreoretinopathy.
Journal Information
Full Title: Invest Ophthalmol Vis Sci
Abbreviation: Invest Ophthalmol Vis Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"all rabbit sequencing data can be accessed at geo accession numbers gse217333."
"Conflicts of Interest: For this project, MSS received sponsored research support from Bayer as part of a research collaboration of the Wilmer Eye Institute with Bayer. MSS is/was a paid advisor to Bayer Healthcare, Revision Therapeutics, Johnson & Johnson, Third Rock Ventures, Novartis Pharmaceuticals, W. L. Gore & Associates, Deerfield, Trinity Partners, Kala Pharmaceuticals, and Acucela. These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. SB is a co-founder and Scientific Advisory Board member of CDI Labs, LLC, and is/was a paid advisor to Third Rock Ventures and Tenpoint Therapeutics. WS is a paid employee of Bayer Pharma AG. KN is a paid employee of Bayer Pharma AG. TZ is paid employee of Bayer Pharma AG. The remaining authors report no conflicts."
"Funded by Bayer AG as part of a sponsored research collaboration with the Wilmer Eye Institute, Johns Hopkins Hospital. Peterson's and Santiago's salary support was provided by NIH T32 OD011089 (PI: Mankowski) and NIH 2T32EY007143 (PI: Zack), respectively. Conflicts of Interest: For this project, MSS received sponsored research support from Bayer as part of a research collaboration of the Wilmer Eye Institute with Bayer. MSS is/was a paid advisor to Bayer Healthcare, Revision Therapeutics, Johnson & Johnson, Third Rock Ventures, Novartis Pharmaceuticals, W. L. Gore & Associates, Deerfield, Trinity Partners, Kala Pharmaceuticals, and Acucela. These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. SB is a co-founder and Scientific Advisory Board member of CDI Labs, LLC, and is/was a paid advisor to Third Rock Ventures and Tenpoint Therapeutics. WS is a paid employee of Bayer Pharma AG. KN is a paid employee of Bayer Pharma AG. TZ is paid employee of Bayer Pharma AG. The remaining authors report no conflicts."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025